Advances in Cardiovascular Science: From Discovery to Translation
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Basic Cardiovascular Sciences (BCVS) Scientific Sessions 2024,held from 22nd to 25th July in Chicago, Illinois.
This event features cutting-edge research and advancements in cardiovascular science, including topics like cardiac gene and cell therapy, tissue engineering, and cardiac metabolism.
Attendees will include basic cardiovascular scientists, molecular and cellular biologists, translational investigators, clinical trialists, and practicing cardiologists.
To connect with Dr. Taubel during the event, please reach out to arrange a meeting.
To find out more, click here.
.svg){kind=small}
-min.jpg)
.jpg)
